# A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV

> **NCT06518408** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital Virgen de las Nieves** · enrollment: 287 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **DRUG:** Cabotegravir Injectable Product
- **DRUG:** Rilpivirine Injectable Product

## Key facts

- **NCT ID:** NCT06518408
- **Lead sponsor:** University Hospital Virgen de las Nieves
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 287 (ACTUAL)
- **Last updated:** 2024-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06518408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06518408, "A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06518408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*